ClinicalTrials.gov
ClinicalTrials.gov Menu

German Adrenocortical Carcinoma Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00453674
Recruitment Status : Recruiting
First Posted : March 29, 2007
Last Update Posted : August 28, 2018
Sponsor:
Collaborator:
Deutsche Krebshilfe e.V., Bonn (Germany)
Information provided by (Responsible Party):
Martin Fassnacht, University of Wuerzburg

March 28, 2007
March 29, 2007
August 28, 2018
January 2003
December 2023   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00453674 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
German Adrenocortical Carcinoma Registry
Deutsches Nebennieren-Karzinom-Register - German Adrenocortical Carcinoma Registry
Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Adrenocortical carcinoma patients in Germany (or treated in Germany)
Adrenocortical Carcinoma
Not Provided
Adrenocortical carcinoma
Adrenocortical carcinoma

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1000
600
December 2025
December 2023   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Histologically confirmed diagnosis of adrenocortical carcinoma
Sexes Eligible for Study: All
Child, Adult, Older Adult
No
Contact: Martin Fassnacht, MD 49-931-201-36507 fassnacht_m@medizin.uni-wuerzburg.de
Contact: Michaela Haaf haaf_m@ukw.de
Germany
 
 
NCT00453674
Wue-ACC-R-86-03
No
Not Provided
Not Provided
Martin Fassnacht, University of Wuerzburg
University of Wuerzburg
Deutsche Krebshilfe e.V., Bonn (Germany)
Principal Investigator: Martin Fassnacht, MD University of Wuerzburg
University of Wuerzburg
August 2018